Narvitas Medical Devices International Ltd
3rd Floor 207 Regent Street W1B 3HH London
Number: 09840390
Incorporation date: 2015-10-26
Dissolution date: 2019-02-26
End of financial year: 31 December
Category: Private Limited Company
Status: Dissolved
Registered at 3rd Floor, London W1B 3HH Narvitas Medical Devices International Limited was categorised as a Private Limited Company registered under the 09840390 Companies House Reg No. This firm appeared on 2015/10/26. Narvitas Medical Devices International Limited had existed on the local market for at least 4 years.
Philip S. was this firm's managing director, designated to this position 9 years ago.
| Profit & Loss | |
|---|---|
| Date of Accounts | 2016-12-31 |
| Currency | |
| Net Worth | -127 379 |
| Balance Sheet | |
| Cash Bank In Hand | 8 092 |
| Current Assets | 10 041 |
| Debtors | 1 949 |
| Net Assets Liabilities Including Pension Asset Liability | -127 379 |
| Tangible Fixed Assets | 28 004 |
| Capital & Reserves | |
| Called Up Share Capital | 5 163 |
| Profit Loss Account Reserve | -442 733 |
| Shareholder Funds | -127 379 |
| Other Financial Data | |
| Creditors Due Within One Year | 165 424 |
| Fixed Assets | 28 004 |
| Net Current Assets Liabilities | -155 383 |
| Number Shares Allotted | 5 163 |
| Par Value Share | 1 |
| Share Capital Allotted Called Up Paid | 5 163 |
| Share Premium Account | 310 191 |
| Tangible Fixed Assets Additions | 32 337 |
| Tangible Fixed Assets Cost Or Valuation | 32 337 |
| Tangible Fixed Assets Depreciation | 4 333 |
| Tangible Fixed Assets Depreciation Charged In Period | 4 333 |
| Total Assets Less Current Liabilities | -127 379 |
Role: Director
Appointed: 26 October 2015
Latest update: 21 May 2023
| Account next due date | 30 September 2018 |
| Account last made up date | 31 December 2016 |
| Confirmation statement next due date | 05 June 2019 |
| Confirmation statement last made up date | 22 May 2018 |
| Annual Accounts 10 July 2017 | |
|---|---|
| Start Date For Period Covered By Report | 2015-10-26 |
| End Date For Period Covered By Report | 2016-12-31 |
| Date Approval Accounts | 10 July 2017 |
(3 pages)